Buyer for CDMO company in Europe

Company to buy

Size: Small to medium business
Sales: 5 – 50 million EUR
Location: Europe
Reason for acquisition: The management wants to expand their business
#CFIE PHB194

Overview of buyer for CDMO company in Europe

The company is a certified silver pharmaceutical company. Now, the buyer is seeking an acquisition opportunity within the pharmaceutical industry. The company is particularly interested in a manufacturing target. Additionally, having a positive EBITDA is seen as an advantageous characteristic.

Profile (strategy) of buyer for CDMO company in Europe

The group has a rich history and an established presence in the pharmaceutical sector with a strong focus on quality and certifications. Further, the company is a prominent laboratory in the Latin American region’s pharmaceutical market. In addition, it excels in developing, manufacturing, and marketing over 1,200 medicines for both human and veterinary use. Over time, they have managed to combine the finest European knowledge and technology with the specific requirements and needs of the discerning Latin American market, all while offering competitive prices.

Subscribe as an interested seller
Contact us to get details about this buyer for CDMO company in Europe

Activities and products of a suitable target

Primarily, the target company should have an excellent status in Europe, reflecting a commitment to quality and rigorous standards. Specifically, they are interested in a company that has developed comprehensive dossiers for pharmaceutical products, enabling international marketing and sales outside of Europe. Also, the desired company should have a strong background in pharmaceutical research, development, manufacturing, and distribution, offering a diverse portfolio of prescription drugs, over-the-counter medications, and healthcare-related products. Moreover, the buyer is also looking for a target company with market expansion potential, including the ability to penetrate new markets, forge strategic partnerships, and explore growth opportunities. Additionally, a positive EBITDA performance is advantageous, indicating a healthy financial performance, profitability, and a sustainable business model.

Highlights

Strong emphasis on quality and certifications, ensuring the reliability and effectiveness of products
Possesses a diverse range of dossiers, enabling market penetration in countries beyond Europe
Strategic focus on acquisitions in the pharmaceutical industry, seeking companies with similar certifications and international market potential
Financially sound with a positive EBITDA, reflecting strong financial performance and profitability

More information on this buyer for CDMO company in Europe

Please get in touch if you are interested in learning more about this buyer for CDMO company in Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CMO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.